Partner Series: Moderna Vaccines Update

Description

The webinar will focus on Moderna’s current and emerging vaccine landscape, including: • mNEXSPIKE • mRESVIA • Overview of Moderna’s respiratory vaccine pipeline • Second-dose recommendations for: o Adults ≥65 years o Immunocompromised populations • Discussion of ongoing public conversations related to mRNA vaccines Each speaker will present separately, followed by a joint Q&A session. Questions related to Moderna products and broader vaccine-related topics will be addressed.